Human Fetal-Derived Neural Stem Cells
Progressive Multiple Sclerosis
IRCCS San RaffaeleCell therapyPhase 1Dormant
CC
46/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 32/ 100
- Competitive Position
- 89/ 100
Competitive context
12 Active assets in the Progressive Multiple Sclerosis cohort.
View all 29 →
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →